Whilst still in infancy, the rise of multispecific drugs that drive induced proximity between otherwise disparate biological targets is shifting the drug discovery paradigm towards therapeutic interventions for previously undrugged, or hard-to-drug targets with clinical value.

As the only industry dedicated forum to radically advance heterobifunctional drug discovery, the 3rd Induced Proximity-Based Drug Discovery Summit is set to unite 50+ key leaders in biopharma and academia who are eager to take a deeper dive into early drug discovery, protein interactions and the novel modalities that are emerging in the space.

Hear from 22+ expert speakers across 3 days of data-driven presentations, technical workshops, and panel discussions to push the therapeutic limits of the field. This is an exclusive opportunity to discover better binders, design efficient heterobifunctionals and accelerate proof of concept gain at the only summit focused on helping you progress your induced proximity pipelines from conception to clinic.

Read on induced-proximity-summit.com/

Continue reading at induced-proximity-summit.com

Health and Wellness

Facebook Share

Twitter Share

Linkedin Share

Email Share